{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-091795","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.849868+00:00","generated_at":"2026-05-30T08:53:46.759750+00:00","sec_items":["8.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Oramed receives ~$1M prepayment on Scilex Tranche A Note; outstanding reduced to $80.2M","bullets":["Received ~$1,000,000 mandatory prepayment on Tranche A Note from Scilex on Oct 24, 2024.","After payment, $80,200,000 of original $101.875M principal repaid or refinanced.","Payment represents 70% of net cash proceeds from Scilex debt/equity financings.","Original Tranche A Note issued Sep 2023; $22.5M exchanged for Tranche B Notes in Oct 2024.","$2.5M of principal exchanged for royalty purchase agreement interest."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-091795","json":"https://secwatch.observer/filing/0001213900-24-091795.json","markdown":"https://secwatch.observer/filing/0001213900-24-091795.md","text":"https://secwatch.observer/filing/0001213900-24-091795.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024091795/0001213900-24-091795-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024091795/ea0219080-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:53:46.759750+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}